EMA
approval
· 2022-05-20
First therapy to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder
Summary
EMA announces the first therapy approved to treat two types of Niemann-Pick disease, a rare genetic metabolic disorder.
Upgrade for the full analysis, importance score, and drug timeline.